- 专利标题: FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS FORMULATIONS WITH AGGREGATE FORMATION
-
申请号: US18030621申请日: 2021-10-06
-
公开(公告)号: US20230372538A1公开(公告)日: 2023-11-23
- 发明人: Jared Bee , Tristan James Marshall , Sherri Van Everen , Stephen Joseph Pakola , Ewa Budzynski
- 申请人: REGENXBIO Inc.
- 申请人地址: US MD Rockville
- 专利权人: REGENXBIO Inc.
- 当前专利权人: REGENXBIO Inc.
- 当前专利权人地址: US MD Rockville
- 国际申请: PCT/US2021/053814 2021.10.06
- 进入国家日期: 2023-04-06
- 主分类号: A61K48/00
- IPC分类号: A61K48/00 ; A61K9/00 ; C07K16/22 ; A61K47/26 ; A61P27/02 ; C12N15/86
摘要:
Provided herein are pharmaceutical compositions for administration to a suprachoroidal space of an eye of a subject. The pharmaceutical compositions can include a recombinant adeno-associated virus (AAV) encoding a transgene. Also provided herein are methods for treating or preventing a disease in a subject by administering a therapeutically effective amount of the pharmaceutical compositions to the subject in need.
信息查询